IP Verse

Liposomes With Lipids Having An Advantageous Pka- Value For Rna Delivery - EP2590626B1

PatentPatent Analysis

EP2590626

GLAXOSMITHKLINE
Application Number
EP11736500A
Filing Date
Jul 6, 2011
Status
Granted And Under Opposition
Apr 12, 2018
Grant Date
Oct 28, 2015
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP4226941B1
EP3682884B1
EP3480209B1

Bibliography

The patent EP2590626B1 was granted to Glaxosmithkline on Oct 28, 2015 following the initial filing on Jul 6, 2011 under the application number EP11736500A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DENNEMEYER & ASSOCIATESJul 28, 2016WITHDRAWN

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents